Aroor Annayya

Temporal activation of p42/44 mitogen-activated protein kinase and c-Jun N-terminal kinase by acetaldehyde in rat hepatocytes and its loss after chronic ethanol exposure.

Phosphotidylethanol mimics ethanol modulation of p42/44 mitogen-activated protein kinase signalling in hepatocytes.

MAP kinase signaling in diverse effects of ethanol.

Role of Ras in ethanol modulation of angiotensin II activated p42/p44 MAP kinase in rat hepatocytes.

Epigenetic effects of ethanol on liver and gastrointestinal injury.

Acetaldehyde alters MAP kinase signalling and epigenetic histone modifications in hepatocytes.

Ethanol inhibition of angiotensin II-stimulated Tyr705 and Ser727 STAT3 phosphorylation in cultured rat hepatocytes: relevance to activation of p42/44 mitogen-activated protein kinase.

Activation of MEK 1/2 and p42/44 MAPK by angiotensin II in hepatocyte nucleus and their potentiation by ethanol.

Differential changes in MAP kinases, histone modifications, and liver injury in rats acutely treated with ethanol.

Elevated activation of ERK1 and ERK2 accompany enhanced liver injury following alcohol binge in chronically ethanol-fed rats.

Binge ethanol intake in chronically exposed rat liver decreases LDL-receptor and increases angiotensinogen gene expression.

Cardiac insulin resistance and microRNA modulators.

Histone H3 phosphorylation (Ser10, Ser28) and phosphoacetylation (K9S10) are differentially associated with gene expression in liver of rats treated in vivo with acute ethanol.

Dysregulated phosphorylation and nuclear translocation of cyclic AMP response element binding protein (CREB) in rat liver after chronic ethanol binge.

A proteomic analysis of liver after ethanol binge in chronically ethanol treated rats.

Mitochondria and Oxidative Stress in the Cardiorenal Metabolic Syndrome.

Insulin resistance and heart failure: molecular mechanisms.

Obesity-Related Alterations in Cardiac Lipid Profile and Nondipping Blood Pressure Pattern during Transition to Diastolic Dysfunction in Male db/db Mice.

Molecular and metabolic mechanisms of cardiac dysfunction in diabetes.

Dipeptidylpeptidase inhibition is associated with improvement in blood pressure and diastolic function in insulin-resistant male Zucker obese rats.

Obesity and insulin resistance induce early development of diastolic dysfunction in young female mice fed a Western diet.

The Novel Angiotensin II Receptor Blocker Azilsartan Medoxomil Ameliorates Insulin Resistance Induced by Chronic Angiotensin II Treatment in Rat Skeletal Muscle.

Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance.

DPP-4 Inhibitors as Therapeutic Modulators of Immune Cell Function and Associated Cardiovascular and Renal Insulin Resistance in Obesity and Diabetes.

Salt loading exacerbates diastolic dysfunction and cardiac remodeling in young female Ren2 rats.

The role of tissue Renin-Angiotensin-aldosterone system in the development of endothelial dysfunction and arterial stiffness.

Uric Acid - key ingredient in the recipe for cardiorenal metabolic syndrome.

Tissue-specific expression of GLP1R in mice: is the problem of antibody nonspecificity solved?

Prevention of obesity-induced renal injury in male mice by DPP4 inhibition.

The pathophysiology of hypertension in patients with obesity.

Fructose and uric acid: is there a role in endothelial function?

Arterial Stiffness: A Nexus between Cardiac and Renal Disease.

Pleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular system.

Dipeptidyl peptidase inhibition prevents diastolic dysfunction and reduces myocardial fibrosis in a mouse model of Western diet induced obesity.

Oxidative stress and obesity: the chicken or the egg?

DPP4 inhibition attenuates filtration barrier injury and oxidant stress in the zucker obese rat.

Estrogen and mitochondria function in cardiorenal metabolic syndrome.

Overnutrition, mTOR signaling, and cardiovascular diseases.

Uric acid promotes left ventricular diastolic dysfunction in mice fed a Western diet.

Mitochondrial functional impairment in response to environmental toxins in the cardiorenal metabolic syndrome.

Dipeptidyl peptidase-4 inhibition ameliorates Western diet-induced hepatic steatosis and insulin resistance through hepatic lipid remodeling and modulation of hepatic mitochondrial function.

Mineralocorticoid receptor antagonism treats obesity-associated cardiac diastolic dysfunction.

Mineralocorticoid receptor blockade prevents Western diet-induced diastolic dysfunction in female mice.

Low-Dose Mineralocorticoid Receptor Blockade Prevents Western Diet-Induced Arterial Stiffening in Female Mice.

Epigenetic histone modifications in a clinically relevant rat model of chronic ethanol-binge-mediated liver injury.

Erratum to: Epigenetic histone modifications in a clinically relevant rat model of chronic ethanol-binge-mediated liver injury.

Vascular stiffness in insulin resistance and obesity.

Endothelial Mineralocorticoid Receptor Deletion Prevents Diet-Induced Cardiac Diastolic Dysfunction in Females.

In Vivo Acute on Chronic Ethanol Effects in Liver: A Mouse Model Exhibiting Exacerbated Injury, Altered Metabolic and Epigenetic Responses.

Endothelial Estrogen Receptor-α Does Not Protect Against Vascular Stiffness Induced by Western Diet in Female Mice.

Endothelial Mineralocorticoid Receptor Mediates Diet-Induced Aortic Stiffness in Females.

Angiotensin II Stimulation of DPP4 Activity Regulates Megalin in the Proximal Tubules.

Glucagon-Like Peptide 1 Receptor Activation and Platelet Function: Beyond Glycemic Control.

Dipeptidyl peptidase-4 inhibition with linagliptin prevents western diet-induced vascular abnormalities in female mice.